Overview

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: - To explore the potential role of tacrolimus in the treatment of membranous nephropathy. - To investigate the safety and tolerability of tacrolimus vs methylprednisolone plus cyclophosphamide.
Phase:
N/A
Details
Lead Sponsor:
Nanjing University School of Medicine
Treatments:
Tacrolimus